Target intelligence / Profile preview

F-actin-capping protein subunit alpha-2 (CAPZA2)

Target
CAPZA2
Molecular classification
Other (Actin-binding structural/regulatory protein)
01

Overview

F-actin-capping protein subunit alpha-2 (CAPZA2) is a structural protein that forms part of the CapZ complex, an α/β heterodimer that binds the barbed (fast-growing) end of actin filaments in a Ca2+-independent manner, preventing addition or loss of actin monomers at this site[1][2][3][4]. CapZ plays a crucial role in organizing myofilaments during muscle development and maintenance, especially at the Z-discs of sarcomeres[1][3]. CAPZA2 is widely expressed in muscle and neuronal tissues, and its proper function is essential for cytoskeletal regulation, muscle contraction, and cellular development; loss-of-function or pathogenic mutations in this gene are associated with severe neurodevelopmental disorders such as global developmental delay, intellectual disability, and hypotonia[2]. Unlike some actin-capping proteins, CapZ does not sever actin filaments[3][4]. CAPZA2 is not a typical drug target, and there are currently no established interacting drugs or biomarker or therapeutic uses directly involving this protein; however, its essentiality for cellular structure and organ development has made it relevant in studies of muscle pathology, genetics, and developmental biology[2][3].

Other names
CapZ-alpha2CAPZA2CAPZCAPPA2CapZ alpha-2F-actin capping protein alpha-2 subunitF-actin-capping protein subunit alpha-2capping actin protein of muscle Z-line alpha subunit 2capping protein (actin filament) muscle Z-line, alpha 2epididymis secretory sperm binding protein
02

Biological functions

Actin filament cappingRegulation of cytoskeleton organizationMyofibril assembly and maintenanceRegulation of actin filament growth and polarityMuscle development and function
03

Disease associations

Neurodevelopmental disorder (developmental delay, intellectual disability, hypotonia, seizures)Focal segmental glomerulosclerosisHypogonadotropic hypogonadismMuscle injury/stress responseOther (via gene mutations)
04

Safety considerations

Potential for developmental toxicity if disruptedEssential for embryonic development (loss-of-function is lethal in animals)

Beyond the preview

Go deeper on F-actin-capping protein subunit alpha-2 (CAPZA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on F-actin-capping protein subunit alpha-2 (CAPZA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call